Lista de obras - Armando Santoro - Dominio Público Uruguay

11C-labeled methionine and evaluation of malignant pleural mesothelioma

artículo científico publicado en 2007

A Dose Escalation Study of RP6530, a Novel Dual PI3K Delta/Gamma Inhibitor, in Patients with Relapsed/Refractory Hematologic Malignancies ⬇️

artículo científico publicado en 2015

A Phase 1b, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma: CC-122-DLBCL-001 ⬇️

scholarly article

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

artículo científico publicado en 2014

A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2013

A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer.

artículo científico publicado en 2008

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer.

artículo científico

A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma

scientific article published on 12 February 2020

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.

artículo científico publicado en 2013

A prospective study on survival in cancer patients with and without venous thromboembolism

artículo científico publicado en 2013

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

artículo científico publicado en 2003

A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.

artículo científico publicado en 2009

A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.

artículo científico publicado en 2009

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

artículo científico publicado en 2014

A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling

artículo científico publicado en 2018

ABVD chemotherapy in the treatment of Hodgkin's disease.

artículo científico publicado en 1982

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients

artículo científico publicado en 2016

Abstract CT215: Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer

scholarly article

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2010

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

artículo científico publicado en 2016

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.

artículo científico publicado en 2009

Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study

artículo científico publicado en 2020

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

artículo científico publicado en 2007

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

artículo científico publicado en 2018

Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation

scientific article published on 25 July 2019

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

artículo científico publicado en 2006

Advanced colorectal liver metastases and surgery after preoperative chemotherapy: is response-based selection enough?

scientific article published on 23 May 2011

Advances in the biology of malignant pleural mesothelioma

scientific article published on February 2011

Advances in the treatment of Hodgkin's disease

artículo científico publicado en 1992

Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases.

artículo científico publicado en 2018

Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate ⬇️

scholarly article

Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma

artículo científico publicado en 2009

Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome

scientific article published on 15 November 2020

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability

artículo científico publicado en 2010

An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumab

artículo científico publicado en 2015

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

scientific article published on 03 December 2016

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

artículo científico publicado en 2007

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer

artículo científico publicado en 2004

Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status

artículo científico publicado en 2006

Anatomy driven optimization strategy for total marrow irradiation with a volumetric modulated arc therapy technique.

artículo científico publicado en 2012

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study

artículo científico publicado en 2017

Aromatase inhibitors in premenopause: Great expectations fulfilled?

artículo científico publicado en 2016

Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment

artículo científico publicado en 2014

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications

artículo científico publicado en 2016

Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience

artículo científico publicado en 2012

Assessment of tumor response in malignant pleural mesothelioma

artículo científico publicado en 2007

Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib.

artículo científico publicado en 2010

Autologous Stem Cell Transplantation Followed By Allogeneic SCT Provides Promising Results in Patients with Relapsed DLBCL and Adverse Prognostic Features Compared with ASCT Alone ⬇️

artículo científico publicado en 2015

Avadomide (CC-122), a Novel Cereblon Modulating Agent, Plus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma ⬇️

scholarly article

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

scientific article published on 01 March 2020

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL).

artículo científico publicado en 2016

B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY

artículo científico publicado en 2014

BM-32CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL.

artículo científico publicado en 2014

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

artículo científico publicado en 2011

Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi

artículo científico publicado en 2014

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.

artículo científico publicado en 2016

Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study

scholarly article

Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma

artículo científico publicado en 2014

Better Outcome with Tandem High DOSE CHEMOTHERAPY and AUTOLOGOUS STEM CELLS TRANSPLANT IN Relapsed/Refractory HODGKIN LYMPHOMA PATIENTS Which Reached COMPLETE REMISSION AFTER Ifosfamide- Gemcitabine-Vinorelbine Scheme (IGEV). ⬇️

artículo científico publicado en 2009

Beyond semantics: the need to better categorize patients with cancer

artículo científico publicado en 2013

Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer

artículo científico publicado en 2020

Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial.

artículo científico publicado en 2016

Biomarkers in Hepatocellular Carcinoma--Letter

scientific article published on 02 August 2012

Bone Marrow (BM) Versus Peripheral Blood Stem Cell (PBSC) For Haploidentical Transplantation With Nonmyeloblative (NMA) Conditioning Regimen and Post Infusion Cyclophosphamide ⬇️

scholarly article

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide

artículo científico publicado en 2014

Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamide.

artículo científico publicado en 2016

Bone-marrow patterns and clinical staging in chronic lymphocytic leukaemia

artículo científico publicado en 1978

Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper

artículo científico

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

artículo científico publicado en 2017

Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers

artículo científico publicado en 2015

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

artículo científico publicado en 2013

Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer

scientific article published on 04 June 2019

CC-122 Degrades the Lymphoid Transcription Factor Aiolos (IKZF3) By Modulating Cereblon and Shows Clinical Activity in a Phase Ib Study of Subjects with Relapsed or Refractory Non-Hodgkin’s Lymphoma and Multiple Myeloma ⬇️

scholarly article

CC-122 Dosing on a Novel Intermittent Schedule Mitigates Neutropenia and Maintains Clinical Activity in Subjects with Relapsed or Refractory Diffuse Large B Cell Lymphoma ⬇️

artículo científico publicado en 2015

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

artículo científico publicado en 2011

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

artículo científico publicado en 2009

CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.

artículo científico publicado en 2007

COVID-19 and liver cancer clinical trials: not everything is lost

scientific article published on 20 May 2020

Cabozantinib for the treatment of hepatocellular carcinoma

artículo científico publicado en 2019

Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study.

artículo científico publicado en 2016

Cancer patients and survivors: changing words or changing culture?

artículo científico publicado en 2013

Cardiac involvement in non-Hodgkin's lymphoma

artículo científico publicado en 2002

Case report of acute aortic dissection during treatment with capecitabine for a late recurrence of breast cancer

artículo científico publicado en 2010

Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide

scientific article published on 13 February 2019

Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study

artículo científico publicado en 2014

Cerebrospinal fluid tumor DNA for liquid biopsy in glioma patients' management: Close to the clinic?

artículo científico publicado en 2020

Ceritinib in ALK-rearranged non-small-cell lung cancer

artículo científico publicado en 2014

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

artículo científico publicado en 2004

Characterisation of the immune-related transcriptome in resected biliary tract cancers

artículo científico publicado en 2017

Checkpoint Inhibition Before Haploidentical Stem Cell Transplantation in Relapsed or Refractory Hodgkin Lymphoma (Hl) Patients is Associated with Higher PFS without Increased Toxicities

scholarly article

Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma

scientific article published on 01 April 2020

Checkpoint inhibitors as treatment for malignant gliomas: "A long way to the top"

scientific article published on 21 June 2018

Checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?

scientific article published on 01 August 2020

Checkpoint inhibitors: 'raising the bar' also in brain metastases from non-small-cell lung cancer?

artículo científico publicado en 2018

Chemotherapy with mitomycin C and capecitabine in patients with advanced colorectal cancer pretreated with irinotecan and oxaliplatin.

artículo científico publicado en 2006

Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma.

artículo científico publicado en 2018

Cisplatin plus gemcitabine on days 1 and 4 every 21 days for solid tumors: result of a dose-intensity study

artículo científico publicado en 2007

Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up

scientific article published on 10 March 2009

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

artículo científico

Clinical Outcome of Stereotactic Ablative Body Radiotherapy for Lung Metastatic Lesions in Non-small Cell Lung Cancer Oligometastatic Patients

artículo científico publicado en 2016

Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study

scientific article published on 23 December 2019

Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologi

artículo científico publicado en 2017

Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases.

artículo científico publicado en 2010

Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

artículo científico publicado en 2020

Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.

artículo científico publicado en 2017

Clinicopathological and Immunohistochemical Characteristics in Male Breast Cancer: A Retrospective Case Series.

artículo científico publicado en 2015

Combined systemic and intrathecal chemotherapy plus radiotherapy in testicular lymphoma: a report of two cases

artículo científico publicado en 2002

Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel

artículo científico publicado en 2024

Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.

artículo científico publicado en 2016

Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

artículo científico publicado en 2015

Complications of therapy and a diagnostic dilemma case. Case 2. Cutaneous toxicity induced by cetuximab

artículo científico publicado en 2003

Comprehensive Geriatric Evaluation in Elderly Patients With Lymphoma: Feasibility of a Patient-Tailored Treatment Plan

scientific article published on 01 February 2003

Conducting Phase I Trials During the SARS-Coronavirus-2 Outbreak: About Science and Care

artículo científico publicado en 2020

Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma.

artículo científico publicado en 2010

Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature

artículo científico publicado en 2017

Copanlisib for the treatment of adults with relapsed follicular lymphoma

artículo científico publicado en 2020

Copanlisib in patients with relapsed or refractory follicular lymphoma

Copy number aberrations of BCL2 and CDKN2A/B identified by array-CGH in thymic epithelial tumors.

artículo científico publicado en 2012

Correction to: The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of pet-guided treatments

scientific article published on 21 November 2020

Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery

artículo científico publicado en 2016

Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY).

artículo científico publicado en 2012

Current Perspectives on Immunotherapy in the Peri-Operative Setting of Muscle-Infiltrating Bladder Cancer

artículo científico publicado en 2020

Current role of autologous and allogeneic stem cell transplantation for relapsed and refractory hodgkin lymphoma.

artículo científico publicado en 2015

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

artículo científico publicado en 2017

Delayed childbearing and female ageing impair assisted reproductive technology outcome in survivors of male haematological cancers

artículo científico publicado en 2018

Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical transplantation.

artículo científico publicado en 2016

Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors

artículo científico publicado en 2011

Development of an immobilization device for Total Marrow Irradiation

artículo científico publicado en 2020

Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes

artículo científico publicado en 2019

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

artículo científico publicado en 1995

Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.

artículo científico publicado en 2014

Driver Somatic Mutations and Transplantation Decision Making in Patients with Myelodysplastic Syndrome ⬇️

artículo científico publicado en 2016

Dual PI3K/ERK inhibition induces necroptotic cell death of Hodgkin Lymphoma cells through IER3 downregulation.

artículo científico publicado en 2016

Durable complete response following chemotherapy and trastuzumab for metastatic HER2-positive breast cancer.

artículo científico publicado en 2012

Durvalumab (Anti PD-L1) As Monotherapy or in Combination Therapy for Relapsed/Refractory (r/r) Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL): A Subgroup Analysis from the Phase 1/2 Fusion NHL-001 Global Multicenter Trial ⬇️

artículo científico publicado en 2019

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.

artículo científico publicado en 2018

ECIL 3-2009 update guidelines for antifungal management

artículo científico publicado en 2011

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

artículo científico publicado en 2007

EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?

artículo científico

EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.

artículo científico publicado en 2006

Early Prediction of Response to Tyrosine Kinase Inhibitors by Quantification of EGFR Mutations in Plasma of NSCLC Patients.

artículo científico publicado en 2015

Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients ⬇️

artículo científico publicado el 15 de octubre de 2010

Early detection, prevention and management of cutaneous adverse events due to sorafenib: recommendations from the Sorafenib Working Group

artículo científico

Early lesions in lymphomas of germinal centre B-cell derivation: evidence and hypotheses

article

Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose

artículo científico publicado en 2006

Early surgical experience with minimally invasive percutaneous approach for patients with metastatic epidural spinal cord compression (MESCC) to poor prognoses

artículo científico publicado en 2011

Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study

scientific article published on 21 March 2018

Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial

artículo científico publicado en 2014

Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung c

artículo científico publicado en 2014

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial

artículo científico publicado en 2012

Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma

artículo científico publicado en 2015

Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: Are we aware of the therapeutic impact of intratumor heterogeneity?

artículo científico publicado en 2018

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

artículo científico publicado en 2003

Erratum to checkpoint inhibitors in primary mediastinal B-cell lymphoma: a step forward in refractory/relapsing patients?

artículo científico publicado en 2020

Evaluation of Interaction Between NK Cells and Colorectal Carcinoma Cells for Development of NK Cell-Based Immunotherapy in Patients with Refractory Disease ⬇️

artículo científico publicado en 2014

Expression and mutational status of c-kit in thymic epithelial tumors

artículo científico publicado en 2010

FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.

artículo científico publicado en 2015

Factors Affecting Outcome of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation Therapy (HDT) with Stem Cell Rescue. ⬇️

scholarly article

Factors Predicting Outcome after Allogeneic Stem Cell Transplantation in Primary Refractory Acute Myeloid Leukemia: A Retrospective Analysis of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO) ⬇️

artículo científico publicado en 2014

Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

artículo científico publicado en 2017

Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available

scientific article published on 01 June 2015

Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection

scientific article published on 20 June 2011

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution

scientific article published on 01 August 2003

Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

artículo científico publicado en 2019

Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer

artículo científico publicado en 2014

First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma

scientific article published on 11 April 2008

First-line extracorporeal photochemotherapy for acute GVHD after unmanipulated haploidentical BMT following nonmyeloablative conditioning and post transplantation CY.

artículo científico publicado en 2013

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

artículo científico publicado en 2020

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

artículo científico publicado en 2014

Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia

artículo científico publicado en 2003

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

artículo científico publicado en 2009

Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics

artículo científico publicado en 2010

Fulvestrant for advanced male breast cancer patients: a case series.

artículo científico publicado en 2011

Future developments in the management of malignant pleural mesothelioma

scientific article published on April 2009

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

artículo científico publicado en 2008

Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up

scientific article published on 24 October 2007

Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases

artículo científico publicado en 2012

Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell Transplantation.

artículo científico publicado en 2018

Haematopoietic stem cell transplantation in adult soft-tissue sarcoma: an analysis from the European Society for Blood and Marrow Transplantation

artículo científico publicado en 2020

Haploidentical Allogeneic Hematopoietic Cell Transplantation for Mantle Cell Lymphoma Using Post-Transplantation Cyclophosphamide Graft-Versus-Host Disease Prophylaxis ⬇️

scholarly article

Haploidentical Stem Cell Transplantation in Lymphomas-Expectations and Pitfalls

scientific article published on 07 November 2020

Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients

artículo científico publicado en 2020

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

artículo científico publicado en 2017

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma.

artículo científico publicado en 2017

Herpes infections in breast cancer patients treated with adjuvant chemotherapy

artículo científico publicado en 2006

High incidence of haemostatic interference in cancer patients treated with FOLFOX regimen and concomitant minidose of warfarin

artículo científico publicado en 2005

High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid.

artículo científico publicado en 2009

High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.

artículo científico publicado en 2007

High-dose chemotherapy followed by autologous hematopoietic stem-cell transplantation for the treatment of solid tumors in adults: a critical review.

artículo científico publicado en 2007

High-dose chemotherapy in poor-prognosis adult small round-cell tumors: clinical and molecular results from a prospective study

artículo científico publicado en 2002

High-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly versus younger lymphoma patients: a matched analysis

scientific article published on 01 August 2003

High-dose melphalan with autologous stem cell support in refractory Hodgkin lymphoma patients as a bridge to second transplant

artículo científico publicado en 2015

How I treat: diagnosing and managing “in situ” lymphoma ⬇️

artículo científico publicado el 11 de enero de 2011

Hypercoagulation Screening As a Marker of Thrombosis and Poor Disease Prognosis in Cancer Patients: The Hypercan Prospective Study ⬇️

artículo científico publicado en 2014

Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study

artículo científico publicado en 2016

Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis.

artículo científico publicado en 2017

Hypofractionated volumetric modulated arc therapy in ductal carcinoma in situ: toxicity and cosmetic outcome from a prospective series.

artículo científico publicado en 2018

Hypofractionation with simultaneous boost in breast cancer patients receiving adjuvant chemotherapy: A prospective evaluation of a case series and review of the literature

artículo científico publicado en 2018

Identification of a Panel of miRNAs Associated with Resistance to Palbociclib and Endocrine Therapy

scholarly article

Identifying and targeting ROS1 gene fusions in non-small cell lung cancer

artículo científico publicado en 2012

Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensus.

artículo científico publicado en 2015

Idiopathic thrombocytopenic purpura and splenic marginal-zone B-cell lymphoma: a casual correlation?

artículo científico publicado en 2003

Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma

artículo científico publicado en 2007

Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy

artículo científico publicado en 2020

Impact ofABCG2polymorphisms on the clinical outcome and toxicity of gefitinib in non-small-cell lung cancer patients

article

In situ follicular lymphoma: pathologic characteristics and diagnostic features.

artículo científico publicado en 2011

Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients

artículo científico publicado en 2009

Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.

artículo científico publicado en 2014

Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.

artículo científico publicado en 2015

Infertility risk and teratogenicity of molecularly targeted anticancer therapy: A challenging issue.

artículo científico publicado en 2016

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

artículo científico publicado en 2009

Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice

scientific article published on 18 November 2020

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.

artículo científico publicado en 2009

Insulin-like growth factor-1 receptor and phosphorylated AKT-serine 473 expression in 132 resected thymomas and thymic carcinomas

artículo científico publicado en 2010

Integrating AI-Powered Digital Pathology and Imaging Mass Cytometry Identifies Key Classifiers of Tumor Cells, Stroma, and Immune Cells in Non–Small Cell Lung Cancer

scholarly article

Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction

artículo científico publicado en 2020

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

artículo científico publicado en 2016

Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma

artículo científico publicado en 2014

Is IDH status the only factor predicting prognosis in newly diagnosed anaplastic glioma patients? Outcome evaluation and prognostic factor analysis in a single-institution large series

artículo científico publicado en 2020

Is gemcitabine cost effective in cancer treatment?

artículo científico publicado en 2007

Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?

artículo científico publicado en 2006

Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment

artículo científico publicado en 2018

Is there an oligometastatic state in pancreatic cancer? Practical clinical considerations raise the question

artículo científico publicado en 2019

Isolated massive meningeal progression in aggressive non Hodgkin's lymphoma

artículo científico publicado en 2002

Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases

artículo científico publicado en 2019

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma ⬇️

scholarly article

Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma

article

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma

artículo científico publicado en 2017

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

scientific article published on 19 September 2019

KRAS mutation in lung metastases from colorectal cancer: prognostic implications

artículo científico publicado en 2015

Lack of response to imatinib mesylate as second-line therapy in a patient with c-kit positive metastatic soft tissue leiomyosarcoma

artículo científico publicado en 2005

Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc ⬇️

artículo científico publicado el 15 de octubre de 2010

Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.

artículo científico publicado en 2017

Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trial

scientific article published on 03 October 2019

Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.

artículo científico publicado en 2011

Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy.

artículo científico publicado en 2013

Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer

scientific article published on 29 July 2008

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography

artículo científico publicado en 2015

Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303.

artículo científico publicado en 2017

Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study

artículo científico publicado en 2019

Long-term, tunneled, noncuffed central venous catheter in cancer patients (Vygon): safety, efficacy, and complications

artículo científico publicado en 2006

Low-dose warfarin prophylaxis for catheter-associated thrombosis in cancer patients. Can it be safely associated with 5-Fluorouracil-based chemotherapy?

artículo científico publicado en 2004

Lung cancer in which the hypothesis of multi-step progression is confirmed by array-CGH results: A case report.

artículo científico publicado en 2015

Lung cancer management: monitoring and treating resistance development in third generation EGFR TKIs

scientific article published on 05 August 2020

Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials.

artículo científico publicado en 2016

Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.

artículo científico publicado en 2007

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

scientific article published on 27 March 2020

Lymphomas

artículo científico publicado en 2002

Lymphomas

artículo científico publicado en 2003

Lymphomas

scientific article published on 01 January 2005

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

artículo científico publicado en 2018

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study

scientific article published on 16 December 2019

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.

artículo científico publicado en 2017

Measurement of Thrombin Generation Is a Positive Predictive Biomarker of V enous Thromboembolism (VTE) in Metastatic Cancer Patients Enrolled in the Hypercan Study ⬇️

artículo científico publicado en 2015

Metastasis of hepatocellular carcinoma to the heart: a case report and review of the literature.

artículo científico publicado en 2004

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.

artículo científico publicado en 2014

Microenvironment-related biomarkers and novel targets in classical Hodgkin's lymphoma

artículo científico

Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

artículo científico publicado en 2003

Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma

artículo científico publicado en 2001

Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma

artículo científico publicado en 2012

Modulation of biliary cancer chemo-resistance through microRNA-mediated rewiring of the expansion of CD133+ cells

artículo científico publicado en 2019

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma.

artículo científico publicado en 2013

Monoclonal antibodies and therapy of human cancers

artículo científico publicado en 2000

Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.

artículo científico publicado en 2008

Multidisciplinary treatment of malignant pleural mesothelioma

artículo científico publicado en 2007

Multimodal Approach to the Management of Metastatic Epidural Spinal Cord Compression (MESCC) Due to Solid Tumors

artículo científico publicado en 2010

Multimodality therapy approaches, local and systemic treatment, compared with chemotherapy alone in recurrent glioblastoma.

artículo científico publicado en 2015

Neutropenic enterocolitis: is there a right timing for surgery? Assessment of a clinical case.

artículo científico publicado en 2007

Never too old to fight breast cancer: A case report.

artículo científico publicado en 2018

New tricks for old biomarkers: thymidylate synthase expression as a predictor of pemetrexed activity in malignant mesothelioma

artículo científico publicado en 2010

Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study

scientific article published on 09 August 2019

Nivolumab Combined with Brentuximab Vedotin (BV) for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma (R/R PMBL): Efficacy and Safety Results from the Phase 2 CheckMate 436 Study

artículo científico publicado en 2019

Nivolumab Treatment Beyond Investigator-Assessed Progression: Extended Follow-up in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 CheckMate 205 Study ⬇️

scholarly article

Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study ⬇️

scholarly article

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

article

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

artículo científico publicado en 2016

Nivolumab in disadvantaged subgroups of metastatic non-small-cell lung cancer patients: a single-institution experience

scientific article published on 14 June 2019

Non-myeloablative conditioning regimen before T-cell replete haploidentical transplantation with post-transplant cyclophosphamide for advanced Hodgkin's and non-Hodgkin's lymphomas

scientific article published on 18 August 2020

Non-peghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity

artículo científico publicado en 2020

Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial

artículo científico publicado en 2015

Non-small cell lung cancer treatment (r)evolution: ten years of advances and more to come.

artículo científico publicado en 2017

Non-small-cell lung cancer patients unsuitable for first-line chemotherapy: a new category of patients for clinical studies?

artículo científico publicado en 2005

Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas

artículo científico publicado en 2014

Novel transforming growth factor beta receptor I kinase inhibitor galunisertib (LY2157299) in advanced hepatocellular carcinoma

artículo científico publicado en 2019

Olfactory system of highly trained dogs detects prostate cancer in urine samples

artículo científico publicado en 2014

Ombrabulin plus cisplatin versus placebo plus cisplatin in patients with advanced soft-tissue sarcomas after failure of anthracycline and ifosfamide chemotherapy: a randomised, double-blind, placebo-controlled, phase 3 trial

artículo científico publicado en 2015

Optimized management of advanced hepatocellular carcinoma: four long-lasting responses to sorafenib

artículo científico publicado en 2011

Oral ulcer as an exclusive sign of gastric cancer: report of a rare case

artículo científico publicado en 2005

Out of specification Tisagenlecleucel is associated with outcomes comparable to standard of care product in relapsed or refractory diffuse large B-cell lymphoma

scholarly article

Outcome Evaluation of HER2 Breast Cancer Patients with Limited Brain Metastasis

artículo científico publicado en 2017

Outcome Evaluation of Oligometastatic Patients Treated with Surgical Resection Followed by Hypofractionated Stereotactic Radiosurgery (HSRS) on the Tumor Bed, for Single, Large Brain Metastases.

artículo científico publicado en 2016

Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.

artículo científico publicado en 2017

Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution.

artículo científico publicado en 2017

Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapy

scientific article published on 13 August 2009

Outcomes for Patients with High-Risk Relapsed or Refractory Indolent B-Cell Lymphoma Treated with Copanlisib in the CHRONOS-1 Study ⬇️

artículo científico publicado en 2018

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) after Treatment with Nivolumab for Relapsed/Refractory Hodgkin Lymphoma ⬇️

artículo científico publicado en 2016

Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation.

artículo científico publicado en 2016

PATH-58. MISMATCH REPAIR DEFICIENCY (MMRd) IN GLIOMA PATIENTS (PTS): FREQUENCY AND CORRELATION WITH CLINICAL, HISTOLOGICAL AND MOLECULAR CHARACTERISTICS

PD-1 Blockade in Anaplastic Thyroid Carcinoma

artículo científico publicado en 2020

PD-1 Inhibitors May Restore Chemo-sensitivity in Relapsed/Refractory Classical Hodgkin Lymphoma

scholarly article

PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy

scientific article published on 26 March 2019

PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy.

artículo científico publicado en 2016

Pathological characterization of nivolumab-related liver injury in a patient with glioblastoma.

artículo científico publicado en 2016

Pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell support

artículo científico publicado en 2009

Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study

artículo científico publicado en 2020

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.

artículo científico publicado en 2008

Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program

artículo científico publicado en 2008

Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.

artículo científico publicado en 2007

Percutaneous vertebral augmentation in metastatic disease: state of the art.

artículo científico publicado en 2011

Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma

artículo científico publicado en 2019

Phase 1 trial of tivantinib in combination with sorafenib in adult patients with advanced solid tumors

artículo científico publicado en 2014

Phase I and pharmacodynamic study of high-dose NGR-hTNF in patients with refractory solid tumours

artículo científico publicado en 2012

Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

artículo científico publicado en 2012

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

artículo científico publicado en 2016

Phase I study of non-pegylated liposomal doxorubicin in combination with ifosfamide in adult patients with metastatic soft tissue sarcomas

artículo científico publicado en 2009

Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments

artículo científico publicado en 2012

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.

artículo científico publicado en 2017

Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

artículo científico publicado en 2019

Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy.

artículo científico publicado en 2012

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

artículo científico publicado en 2010

Phase II study of afatinib, an irreversible ErbB family blocker, in EGFR FISH-positive non-small-cell lung cancer.

artículo científico publicado en 2015

Phase II study of asparagine-glycine-arginine-human tumor necrosis factor alpha, a selective vascular targeting agent, in previously treated patients with malignant pleural mesothelioma

artículo científico publicado en 2010

Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis

scientific article published on 22 August 2018

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma

artículo científico publicado en 2013

Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma

artículo científico publicado en 2006

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

scientific article published on 14 August 2006

Phase II study of tivantinib (ARQ 197) and cetuximab in patients with EGFR inhibitor-resistant, MET-High, KRAS wild-type (KRASwt) metastatic colorectal cancer (mCRC)

artículo científico publicado en 2017

Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer

artículo científico publicado en 2007

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

artículo científico publicado en 2007

Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung Cancer.

artículo científico publicado en 2015

Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial

artículo científico publicado en 2016

Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy

artículo científico publicado en 2010

Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma

artículo científico publicado en 2008

Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer

artículo científico publicado en 2012

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

scientific article published on 30 June 2009

Phase Ib study of combinations of avadomide (CC‐122), CC‐223, CC‐292, and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma

Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma

artículo científico publicado en 2017

Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?

artículo científico publicado en 2019

Positron emission tomography response at the time of autologous stem cell transplantation predicts outcome of patients with relapsed and/or refractory Hodgkin's lymphoma responding to prior salvage therapy.

artículo científico publicado en 2012

Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: a retrospective analysis of the Rete Ematologica Lombarda

scientific article published on 03 May 2015

Postmastectomy radiation therapy using VMAT technique for breast cancer patients with expander reconstruction

scientific article published on 25 April 2019

Postoperative chemoradiotherapy or surgery alone for gastric cancer: the plausibility of the question and pertinence of the answer

artículo científico publicado en 2010

Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: a single institution experience.

artículo científico publicado en 2013

Preclinical assessment of volumetric modulated arc therapy for total marrow irradiation.

artículo científico publicado en 2011

Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin

artículo científico publicado en 2011

Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients

artículo científico publicado en 2018

Predictive value of early 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) during salvage chemotherapy in relapsing/refractory Hodgkin lymphoma (HL) treated with high-dose chemotherapy.

artículo científico publicado en 2009

Preliminary Results of a Randomized Study on Postmenopausal Women With Early Stage Breast Cancer: Adjuvant Hypofractionated Whole Breast Irradiation Versus Accelerated Partial Breast Irradiation (HYPAB Trial)

scientific article published on 09 September 2020

Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide

scientific article published on 08 November 2019

Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL). ⬇️

scholarly article

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study ⬇️

artículo científico

Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study

artículo científico publicado en 2005

Primary mediastinal B-cell lymphoma with sclerosis: report of 11 cases treated with intensified-CHOP plus radiotherapy

artículo científico publicado en 2005

Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case report

scientific article published on 01 December 2019

Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment.

artículo científico

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patients

artículo científico publicado en 2008

Prognostic and predictive role of [18 F]fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with unresectable malignant pleural mesothelioma (MPM) treated with up-front pemetrexed-based chemotherapy.

artículo científico publicado en 2017

Prognostic and predictive value of MET deregulation in non-small cell lung cancer

artículo científico

Prognostic factors and outcome of HER2+ breast cancer with CNS metastases

artículo científico publicado en 2020

Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens--a European Organization for Research and Treatment of Cancer Soft Tissue and

artículo científico publicado en 1999

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

artículo científico publicado en 2014

Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis

artículo científico publicado en 2020

Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

artículo científico publicado en 2017

Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery?

artículo científico publicado en 2018

Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients

artículo científico publicado en 2006

Prophylaxis of central venous catheter-related thrombosis with minidose warfarin: analysis of its use in 427 cancer patients.

artículo científico publicado en 2005

Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients

artículo científico publicado en 2011

Prostatic stromal tumor with fatal outcome in a young man: histopathological and immunohistochemical case presentation.

artículo científico publicado en 2010

Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: A case report on the therapeutic regimen

scientific article published on 01 August 2019

Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study

artículo científico publicado en 2012

Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma.

artículo científico publicado en 2014

Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?

artículo científico publicado en 2016

Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas

artículo científico

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

artículo científico publicado en 2013

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

artículo científico publicado en 2012

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

artículo científico

Rapid and Wide Immunereconstitution Obtained with HSV-TK Engineered Donor Lymphocyte Add-Backs Permits Long-Term Survival after haplo-HSCT. ⬇️

artículo científico publicado en 2006

Re-challenge with catumaxomab in patients with malignant ascites: results from the SECIMAS study

artículo científico publicado en 2014

Re-irradiation of metastatic spinal cord compression: A feasibility study by volumetric-modulated arc radiotherapy for in-field recurrence creating a dosimetric hole on the central canal

artículo científico publicado en 2010

Rectal squamous cell carcinoma treated with chemoradiotherapy: report of six cases

artículo científico publicado en 2010

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

artículo científico publicado en 2004

Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomas

artículo científico publicado en 2002

Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer

scientific article published on 01 July 2007

Reduced-intensity allogeneic transplantation in patients with refractory or progressive Hodgkin's disease after high-dose chemotherapy and autologous stem cell infusion

artículo científico publicado en 2007

Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram

artículo científico publicado en 2024

Refining sorafenib therapy: lessons from clinical practice.

artículo científico

Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study

artículo científico publicado en 2013

Regorafenib for the treatment of unresectable hepatocellular carcinoma.

artículo científico

Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications.

artículo científico publicado en 2018

Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND)

scientific article published on 20 November 2019

Reply to Y. Pointreau et al

Reproducibility of the WHO classification of thymomas: practical implications

artículo científico publicado en 2012

Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study.

artículo científico publicado en 2016

Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.

artículo científico publicado en 2011

Response: Re: Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients with 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

artículo científico publicado en 2011

Retroperitoneal Sarcoma: Is It Time to Change the Surgical Policy?

artículo científico publicado en 2011

Retroperitoneal sarcoma: is it time to change the surgical policy?

artículo científico publicado en 2011

Rituximab in thrombotic microangiopathy

scientific article published on 01 October 2007

Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

artículo científico publicado en 2008

Role of naive-derived T memory stem cells in T-cell reconstitution following allogeneic transplantation.

artículo científico publicado en 2015

Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study

artículo científico publicado en 2016

SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2014

STAGING FOR CHRONIC LYMPHOCYTIC LEUKÆMIA

artículo científico publicado en 1979

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.

artículo científico publicado en 2017

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.

artículo científico publicado en 2017

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: final results of a phase II study conducted by the Fondazione Italiana Linfomi

artículo científico publicado en 2016

Salvage Therapy for Hodgkin's Lymphoma: A Review of Current Regimens and Outcomes

artículo científico publicado en 2020

Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma. ⬇️

artículo científico publicado en 2009

Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.

artículo científico publicado en 2011

Second-line treatment for malignant pleural mesothelioma

scientific article published on 29 October 2009

Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).

artículo científico publicado en 2017

Short schedule of cisplatin and vinorelbine: a dose-finding study in non-small-cell lung cancer

scientific article published on 01 January 2006

Single-agent high-dose melphalan followed by peripheral blood stem cell (PBSC) in lymphoma patients: an effective, and well-tolerated conditioning regimen

artículo científico publicado en 2004

Single-cell profiling defines the prognostic benefit of CD39<sup>high</sup> tissue resident memory CD8+ T cells in luminal-like breast cancer

artículo científico publicado en 2021

Solitary plasmacytoma of the duodenum

scientific article published on 01 June 2004

Sorafenib in Hepatitis C Virus-Negative Patients With Hepatocellular Carcinoma: Don't Throw the Baby Out With the Bathwater!

artículo científico publicado en 2017

Sorafenib in advanced hepatocellular carcinoma

artículo científico publicado en 2008

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis

article

Sorafenib is active on lung metastases from synovial sarcoma

artículo científico publicado en 2009

Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial.

artículo científico publicado en 2009

Sorafenib: a review of its use in advanced hepatocellular carcinoma

artículo científico publicado en 2009

Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study.

artículo científico publicado en 2011

Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach

artículo científico publicado en 2014

Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.

artículo científico publicado en 2015

Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.

artículo científico publicado en 2016

Surgery Followed by Radiotherapy for the Treatment of Metastatic Epidural Spinal Cord Compression From Breast Cancer

artículo científico publicado en 2011

Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients: A 18-Year Experience at a Single High-volume Referral Center

artículo científico publicado en 2019

Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer

scientific article published on 11 November 2019

Synergistic Induction of Cell Death in Hodgkin Lymphoma Cells By the Novel PI3K Inhibitor RP6530 Combined with Brentuximab Vedotin (SGN-35) through Inhibition of Tumor Angiogenesis ⬇️

artículo científico publicado en 2015

T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment Immunosuppression

artículo científico publicado en 2024

T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identica

artículo científico publicado en 2017

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes.

artículo científico publicado en 2015

Tacrolimus (FK) Compared to Cyclosporine a (CyA) after Haploidentical T Cell Replete Stem Cell Transplantation (Haplo-SCT) with Post-Infusion Cyclophosphamide: A Retrospective Analysis ⬇️

artículo científico publicado en 2014

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

scientific article published on 23 November 2015

Tandem autologous-allo-SCT is feasible in patients with high-risk relapsed non-Hodgkin's lymphoma

artículo científico publicado en 2012

Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients.

artículo científico publicado en 2015

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.

artículo científico publicado en 2017

Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.

artículo científico publicado en 2007

Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports.

artículo científico

Targeting cancer cells and tumor microenvironment in preclinical and clinical models of Hodgkin lymphoma using the dual PI3Kδ/γ inhibitor RP6530

article

Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review

artículo científico publicado en 2012

The "old drug" dacarbazine as a second/third line chemotherapy in advanced soft tissue sarcomas

artículo científico publicado en 2007

The 70-year-old newly diagnosed glioblastoma patients are older than the 65-year-old? Outcome evaluation of the two categories in a matched case control study with propensity score balancing

artículo científico publicado en 2020

The Advantages of Clinical Nutrition Use in Oncologic Patients in Italy: Real World Insights

scientific article published on 06 May 2020

The Blurred Line between the Art and Science of Medicine

artículo científico publicado en 2020

The CIBMTR score predicts survival of AML patients undergoing allogeneic transplantation with active disease after a myeloablative or reduced intensity conditioning: a retrospective analysis of the Gruppo Italiano Trapianto Di Midollo Osseo

artículo científico publicado en 2013

The PI3K/ERK Dual Inhibitor AEZS-136 Induces ROS-Dependent Necroptotic Cell Death and Exerts Potent Antitumor Effects In NOD/SCID Mice With Hodgkin Lymphoma Cell Line Xenografts ⬇️

artículo científico publicado en 2013

The Role of Donor CMV Serostatus on Outcome after T-Cell Replete Haplo-SCT and Post-Transplant Cyclophosphamide: A Cohort Analysis on 207 Consecutive Adult Patients ⬇️

scholarly article

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

artículo científico publicado en 2016

The classic prognostic factors in advanced Hodgkin's lymphoma patients are losing their meaning at the time of Pet-guided treatments

scientific article published on 23 December 2019

The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation.

artículo científico publicado en 2018

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

artículo científico publicado en 2010

The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer

artículo científico publicado en 2018

The efficacy of hybrid chemotherapy with intravenous oxaliplatin and folinic acid and intra-hepatic infusion of 5-fluorouracil in patients with colorectal liver metastases: a phase II study

artículo científico publicado en 2007

The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies

artículo científico publicado en 2005

The neural phenotype in invasive urothelial carcinoma patients: Alternative score detection and prognostic implication.

artículo científico publicado en 2020

The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide

artículo científico publicado en 2019

The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest.

artículo científico publicado en 2016

The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide.

artículo científico publicado en 2016

The present and the future landscape of treatment of advanced hepatocellular carcinoma.

artículo científico publicado en 2010

The radiologist empowerment through virtual multidisciplinary tumor boards: The commitment of oncologic care during COVID-19 pandemic

artículo científico publicado en 2020

The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer.

artículo científico publicado en 2012

The role of inflammation in lymphoma.

artículo científico

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi.

artículo científico publicado en 2013

The use of radiation therapy for oligoprogressive/oligopersistent oncogene-driven non small cell lung cancer: State of the art

scientific article published on 05 February 2020

Therapeutic and Mobilizing Activity of a Vinorelbine, Ifosfamide and Cytarabine Regimen (VIHA) as Salvage Regimen In Resistant/Relapse Non Hodgkin Lymphoma (NHL) ⬇️

artículo científico publicado en 2010

Three-week versus four-week schedule of cisplatin and gemcitabine: results of a randomized phase II study

artículo científico publicado en 2002

Thrombin Generation and D-Dimer for Prediction of Disease Progression and Mortality in Patients with Metastatic Gastrointestinal Cancer

artículo científico publicado en 2022

Thrombin generation predicts for early recurrence in breast cancer patients

scientific article published on 12 May 2020

Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer

artículo científico publicado en 2019

Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin

Thymoma associated with myasthenia and autonomic anti-Hu paraneoplastic neuropathy

scientific article published on 01 March 2009

Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET--letter

artículo científico publicado en 2013

Tivantinib for hepatocellular carcinoma

Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study

article

Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study.

artículo científico publicado en 2012

Tivantinib in MET-high hepatocellular carcinoma patients and the ongoing Phase III clinical trial

scientific article published on 29 January 2014

Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? The experience of Italian centers.

artículo científico publicado en 2015

Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma

artículo científico publicado en 2013

Trabectedin for the treatment of soft tissue sarcomas.

artículo científico publicado en 2016

Trastuzumab beyond progression: a challenge to translational oncology?

artículo científico publicado en 2010

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

artículo científico publicado en 2016

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma.

artículo científico publicado en 2017

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

artículo científico publicado en 2017

Uncommon manifestations of common malignancies: case 1. Soft-tissue metastases from malignant pleural mesothelioma

scientific article published on 01 August 2004

Unexpected low efficacy of stealth liposomal doxorubicin (Caelyx) and vinorelbine in metastatic breast cancer

artículo científico publicado en 2003

Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies

artículo científico publicado en 2015

Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach.

artículo científico publicado en 2018

Upregulation of Cereblon Expression By the DNA Methyltransferase Inhibitor Azacytidine Strongly Enhances Lenalidomide Cytotoxicity in Germinal Center B-Cell-like (GCB) and Activated B-Cell-like (ABC) Diffuse Large B-Cell Lymphoma (DLBCL) ⬇️

artículo científico publicado en 2014

Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme

article

Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma.

artículo científico publicado en 2012

Utility of 18F-FDG PET and contrast-enhanced CT scan in the assessment of residual liver metastasis from colorectal cancer following adjuvant chemotherapy.

artículo científico publicado en 2007

Utility of the Khorana and the new-Vienna CATS prediction scores in cancer patients of the HYPERCAN cohort

artículo científico publicado en 2023

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy.

artículo científico publicado en 2016

Vertebral metastases reirradiation with volumetric-modulated arc radiotherapy

artículo científico publicado en 2012

Vertebroplasty for pain relief and spinal stabilization in multiple myeloma

artículo científico publicado en 2010

Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

artículo científico publicado en 2013

Vismodegib in the treatment of basal cell carcinoma: indications for clinical practice

artículo científico

Volumetric Modulation Arc Radiotherapy Compared With Static Gantry Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma Tumor: A Feasibility Study

artículo científico publicado en 2010

Weekly non-pegylated liposomal doxorubicin chemotherapy in heavily pre-treated patients with metastatic breast cancer.

artículo científico publicado en 2013

What is the best option to cure patients with resistant/relapsing Hodgkin's disease?

artículo científico publicado en 2006

Lista de obras de Armando Santoro

11C-labeled methionine and evaluation of malignant pleural mesothelioma

A Dose Escalation Study of RP6530, a Novel Dual PI3K Delta/Gamma Inhibitor, in Patients with Relapsed/Refractory Hematologic Malignancies ⬇️

A Phase 1b, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma: CC-122-DLBCL-001 ⬇️

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma

A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer.

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer.

A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma

A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practice.

A prospective study on survival in cancer patients with and without venous thromboembolism

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

A randomized phase III study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer.

A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.

A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study

A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling

ABVD chemotherapy in the treatment of Hodgkin's disease.

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients

Abstract CT215: Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma.

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.

Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

Advanced colorectal liver metastases and surgery after preoperative chemotherapy: is response-based selection enough?

Advances in the biology of malignant pleural mesothelioma

Advances in the treatment of Hodgkin's disease

Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases.

Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate ⬇️

Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma

Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome

Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability

An exploratory biomarker study in metastatic tumors from colorectal cancer patients treated with bevacizumab

An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy

Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer

Anatomic location of breast cancer micrometastasis in sentinel lymph node predicts axillary status

Anatomy driven optimization strategy for total marrow irradiation with a volumetric modulated arc therapy technique.

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study

Aromatase inhibitors in premenopause: Great expectations fulfilled?

Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment

Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications

Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience

Assessment of tumor response in malignant pleural mesothelioma

Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib.

Autologous Stem Cell Transplantation Followed By Allogeneic SCT Provides Promising Results in Patients with Relapsed DLBCL and Adverse Prognostic Features Compared with ASCT Alone ⬇️

Avadomide (CC-122), a Novel Cereblon Modulating Agent, Plus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma ⬇️

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

B-IGEV (bortezomib plus IGEV) versus IGEV before high-dose chemotherapy followed by autologous stem cell transplantation in relapsed or refractory Hodgkin lymphoma: a randomized, phase II trial of the Fondazione Italiana Linfomi (FIL).

B-cell reconstitution recapitulates B-cell lymphopoiesis following haploidentical BM transplantation and post-transplant CY

BM-32CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL.

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

Bendamustine combined with donor lymphocytes infusion in Hodgkin's lymphoma relapsing after allogeneic hematopoietic stem cell transplantation

Bendamustine for Hodgkin lymphoma patients failing autologous or autologous and allogeneic stem cell transplantation: a retrospective study of the Fondazione Italiana Linfomi

Bendamustine in Combination With Gemcitabine and Vinorelbine Is an Effective Regimen As Induction Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma: Final Results of a Multicenter Phase II Study.

Bendamustine in Combination with Gemcitabine and Vinorelbine (BEGEV) is an Effective Regimen for Heavily Pretreated, Relapsed or Refractory Hodgkin Lymphoma Patients: A Retrospective Study

Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma

Better Outcome with Tandem High DOSE CHEMOTHERAPY and AUTOLOGOUS STEM CELLS TRANSPLANT IN Relapsed/Refractory HODGKIN LYMPHOMA PATIENTS Which Reached COMPLETE REMISSION AFTER Ifosfamide- Gemcitabine-Vinorelbine Scheme (IGEV). ⬇️

Beyond semantics: the need to better categorize patients with cancer

Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer

Biomarker Analyses of Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib with or without Erlotinib in the SEARCH Trial.

Biomarkers in Hepatocellular Carcinoma--Letter

Bone Marrow (BM) Versus Peripheral Blood Stem Cell (PBSC) For Haploidentical Transplantation With Nonmyeloblative (NMA) Conditioning Regimen and Post Infusion Cyclophosphamide ⬇️

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide

Bone marrow donor-related variables associated with harvest outcome in HLA-haploidentical transplantation with postinfusion cyclophosphamide.

Bone-marrow patterns and clinical staging in chronic lymphocytic leukaemia

Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

Brentuximab vedotin in patients with Hodgkin lymphoma and a failed allogeneic stem cell transplantation: results from a named patient program at four Italian centers

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer

CC-122 Degrades the Lymphoid Transcription Factor Aiolos (IKZF3) By Modulating Cereblon and Shows Clinical Activity in a Phase Ib Study of Subjects with Relapsed or Refractory Non-Hodgkin’s Lymphoma and Multiple Myeloma ⬇️

CC-122 Dosing on a Novel Intermittent Schedule Mitigates Neutropenia and Maintains Clinical Activity in Subjects with Relapsed or Refractory Diffuse Large B Cell Lymphoma ⬇️

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer

CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study

CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.

COVID-19 and liver cancer clinical trials: not everything is lost